Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for IRIDEX Corporation (IRIX : NSDQ)
 
 • Company Description   
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.

Number of Employees: 93

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.89 Daily Weekly Monthly
20 Day Moving Average: 64,357 shares
Shares Outstanding: 16.79 (millions)
Market Capitalization: $14.94 (millions)
Beta: 0.57
52 Week High: $2.41
52 Week Low: $0.78
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -7.28% -10.69%
12 Week 4.72% -15.81%
Year To Date -47.02% -49.72%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1212 Terra Bella Avenue
-
Mountain View,CA 94043
USA
ph: 650-940-4700
fax: 650-940-4710
investors@iridex.com http://www.iridex.com
 
 • General Corporate Information   
Officers
Patrick Mercer - Chief Executive Officer
Scott Shuda - Chairperson of the Board
Romeo R. Dizon - Chief Financial Officer
Robert Grove - Director
Beverly A. Huss - Director

Peer Information
IRIDEX Corporation (CYBE)
IRIDEX Corporation (QPCI)
IRIDEX Corporation (CLZR)
IRIDEX Corporation (DYSL)
IRIDEX Corporation (XLTC)
IRIDEX Corporation (PLSIQ)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: LASERS-SYS/COMP
Sector: Computer and Technology
CUSIP: 462684101
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
Share - Related Items
Shares Outstanding: 16.79
Most Recent Split Date: (:1)
Beta: 0.57
Market Capitalization: $14.94 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/14/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 17.54
Price/Cash Flow: -
Price / Sales: 0.31
EPS Growth
vs. Year Ago Period: 52.38%
vs. Previous Quarter: -100.00%
Sales Growth
vs. Year Ago Period: 1.15%
vs. Previous Quarter: -6.30%
ROE
06/30/25 - -
03/31/25 - -290.57
12/31/24 - -230.62
ROA
06/30/25 - -
03/31/25 - -22.86
12/31/24 - -28.60
Current Ratio
06/30/25 - -
03/31/25 - 1.95
12/31/24 - 1.42
Quick Ratio
06/30/25 - -
03/31/25 - 1.27
12/31/24 - 0.77
Operating Margin
06/30/25 - -
03/31/25 - -14.61
12/31/24 - -18.31
Net Margin
06/30/25 - -
03/31/25 - -14.61
12/31/24 - -18.31
Pre-Tax Margin
06/30/25 - -
03/31/25 - -14.53
12/31/24 - -18.17
Book Value
06/30/25 - -
03/31/25 - 0.05
12/31/24 - 0.13
Inventory Turnover
06/30/25 - -
03/31/25 - 2.67
12/31/24 - 2.66
Debt-to-Equity
06/30/25 - -
03/31/25 - 4.28
12/31/24 - 0.48
Debt-to-Capital
06/30/25 - -
03/31/25 - 34.72
12/31/24 - 32.38
 

Powered by Zacks Investment Research ©